Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University improves upon traditional methods of targeting bladder cancer cells with ...
The team applied this method to mRNA/saRNA constructs from 1 to 10 kb and assessed pH ranges from 3 to 6. For all the RNA constructs, the J2 immunoblot signal—a marker for dsRNA strands—decreased with ...
UT Austin and Sanofi partner to build tool that predicts translation efficiency of mRNA sequences. A new artificial intelligence model can improve the process of drug and vaccine discovery by ...
News Medical on MSN
Purdue-developed LENN system enhances stability and targeting of mRNA cancer therapies
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
We asked experts about how the technology works, its safety and its potential in medicine. By Nina Agrawal Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA vaccines ...
Imagine a cancer treatment that precisely targets malignant cells, leaving healthy ones untouched. Consider, also, a cancer treatment that corrects abnormal protein synthesis to produce healthy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results